Citations (8)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (4)
Qing Huang, Bruno Emond, Marie-Hélène Lafeuille, Deepshekhar Gupta, Patrick Lefebvre, Murali Sundaram & Anthony Mato. (2020) Healthcare resource utilization and costs associated with first-line ibrutinib compared to chemoimmunotherapy treatment among Medicare beneficiaries with chronic lymphocytic leukemia. Current Medical Research and Opinion 36:12, pages 2009-2018.
Read now
Read now
Vibor Milunović, Karla Mišura Jakobac, Inga Mandac Rogulj, Marko Martinović, Delfa Radić-Krišto & Slobodanka Ostojić Kolonić. (2020) The fading star of obinutuzumab-chlorambucil regimen in patients with comorbidities with chronic lymphocytic leukemia – are we ready for chemo-free immunotherapy approach?. Expert Review of Hematology 13:7, pages 771-779.
Read now
Read now
Driss Chaoui, Sylvain Choquet, Laurence Sanhes, Béatrice Mahé, Maya Hacini, Olivier Fitoussi, Yazid Arkam, Hubert Orfeuvre, Marie-Sarah Dilhuydy, Marly Barry, Eric Jourdan, Brigitte Dreyfus, Adrian Tempescul, Stéphane Leprêtre, Aurélie Bardet, Pierre Leconte, Marc Maynadié & Alain Delmer. (2017) Relapsed chronic lymphocytic leukemia retreated with rituximab: interim results of the PERLE study. Leukemia & Lymphoma 58:6, pages 1366-1375.
Read now
Read now
Caroline Dartigeas, Eric Van Den Neste, Christian Berthou, Hervé Maisonneuve, Stéphane Leprêtre, Marie-Sarah Dilhuydy, Marie-Christine Béné, Florence Nguyen-Khac, Rémi Letestu, Florence Cymbalista, Sophie De Guibert, Thérèse Aurran, Kamel Laribi, Jean-Pierre Vilque, Olivier Tournilhac, Alain Delmer, Pierre Feugier, Bruno Cazin, Anne-Sophie Michallet, Vincent Lévy, Xavier Troussard, Roselyne Delepine, Elsa Tavernier, Philippe Colombat & Véronique Leblond. (2016) Evaluating abbreviated induction with fludarabine, cyclophosphamide, and dose-dense rituximab in elderly patients with chronic lymphocytic leukemia. Leukemia & Lymphoma 57:2, pages 328-334.
Read now
Read now
Articles from other publishers (4)
Mahmood Hassan Dalhat, Hisham N. Altayb, Mohammad Imran Khan & Hani Choudhry. (2021) Structural insights of human N-acetyltransferase 10 and identification of its potential novel inhibitors. Scientific Reports 11:1.
Crossref
Crossref
Yair Herishanu, Tamar Tadmor, Andrei Braester, Osnat Bairey, Ariel Aviv, Naomi Rahimi‐Levene, Riva Fineman, Itai Levi, Mona Yuklea, Rosa Ruchlemer, Lev Shvidel & Aaron Polliack. (2019) Low‐dose fludarabine and cyclophosphamide combined with standard dose rituximab (LD‐FCR) is an effective and safe regimen for elderly untreated patients with chronic lymphocytic leukemia: The Israeli CLL study group experience. Hematological Oncology 37:2, pages 185-192.
Crossref
Crossref
Stephan Stilgenbauer, Veronique Leblond, Robin Foà, Sebastian Böttcher, Osman Ilhan, Wolfgang Knauf, Eva Mikuskova, Christoph Renner, Eugen Tausch, Dariusz Woszczyk, Ekaterina Gresko, Linda Lundberg, Tom Moore, Thea Morris, Susan Robson & Francesc Bosch. (2018) Obinutuzumab plus bendamustine in previously untreated patients with CLL: a subgroup analysis of the GREEN study. Leukemia 32:8, pages 1778-1786.
Crossref
Crossref
Pariket M. Dubal, Rahul Dutta, Alejandro Vazquez, Tapan D. Patel, Soly Baredes & Jean Anderson Eloy. (2015) A comparative population-based analysis of sinonasal diffuse large B-cell and extranodal NK/T-cell lymphomas. The Laryngoscope 125:5, pages 1077-1083.
Crossref
Crossref